ArticleFrontiers in immunology2020

Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model.

Rafael Kroon Campos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.